24 research outputs found

    A phase 2 trial of a topical antiseptic bundle in head and neck cancer surgery: Effects on surgical site infection and the oral microbiome

    Get PDF
    BACKGROUND: Head and neck cancer (HNC) surgery remains an important component of management but is associated with a high rate of surgical site infection (SSI). We aimed to assess the safety and efficacy of a topical mucosal antiseptic bundle in preventing SSI and evaluate microbial predictors of infection through a genomic sequencing approach. METHODS: This study was an open-label, single-arm, single-center, phase 2 trial of a topical mucosal antiseptic bundle in patients with HNC undergoing aerodigestive tract resection and reconstruction. Patients underwent topical preparation of the oral mucosa with povidone-iodine (PI) and chlorhexidine gluconate (CHG) pre- and intra-operatively followed by oral tetracycline ointment every 6 hours for 2 days post-operatively. The primary outcome was change in bacterial bioburden at the oral surgical site. Secondary outcomes included safety, SSI, and microbial predictors of infection. FINDINGS: Of 27 patients screened between January 8, 2021, and May 14, 2021, 26 were enrolled and 25 completed the study. There were no antiseptic-related adverse events. The topical mucosal antiseptic bundle significantly decreased oral bacterial colony-forming units from pre-operative levels (log INTERPRETATION: The bacterial strains which subsequently caused SSI were frequently identified in the pre-operative oral cavity. Accordingly, a topical antiseptic bundle decreased oral bacterial bioburden throughout the peri-operative period and was associated with a low rate of SSI, supporting further study of topical antisepsis in HNC surgery. FUNDING: Alliance Oncology

    Association Between Observer-Rated Disfigurement and Body Image-Related Distress Among Head and Neck Cancer Survivors

    Get PDF
    This cross-sectional study assesses the association between observer-rated disfigurement and body image–related distress among survivors of head and neck cancer

    Association of Inventory to Measure and Assess imaGe Disturbance - Head and Neck Scores With Clinically Meaningful Body Image-Related Distress Among Head and Neck Cancer Survivors

    Get PDF
    Objective: The Inventory to Measure and Assess imaGe disturbance - Head and Neck (IMAGE-HN) is a validated patient-reported outcome measure of head and neck cancer-related body image-related distress (BID). However, the IMAGE-HN score corresponding to clinically relevant BID is unknown. The study objective is to determine the IMAGE-HN cutoff score that identifies head and neck cancer patients with clinically relevant BID. Methods: We conducted a cross-sectional study at six academic medical centers. Individuals ≥18 years old with a history of head and neck cancer treated with definitive intent were included. The primary outcome measure was the IMAGE-HN. A Receiver Operating Characteristic curve analysis was performed to identify the IMAGE-HN score that maximized sensitivity and specificity relative to a Body Image Scale score of ≥10 (which indicates clinically relevant BID in a general oncology population). To confirm the validity of the IMAGE-HN cutoff score, we compared the severity of depressive [Patient Health Questionnaire-9 (PHQ-9)] and anxiety symptoms [Generalized Anxiety Disorder-7 (GAD-7)], and quality of life [University of Washington-QOL (UW-QOL)] in patients with IMAGE-HN scores above and below the cutoff. Results: Of the 250 patients, 70.4% were male and the mean age was 62.3 years. An IMAGE-HN score of ≥22 was the optimal cutoff score relative to a Body Image Scale score of ≥10 and represents a clinically relevant level of head and neck cancer-related BID. Relative to those with an IMAGE-HN score of \u3c22, patients with IMAGE-HN scores of ≥22 had a clinically meaningful increase in symptoms of depression (mean PHQ-9 score difference = 5.8) and anxiety (mean GAD-7 score difference = 4.1) as well as worse physical (mean UW-QOL score difference = 18.9) and social-emotional QOL (mean UW-QOL score difference = 21.5). Using an IMAGE-HN cutoff score ≥22, 28% of patients had clinically relevant BID. Conclusion: An IMAGE-HN score of ≥22 identifies patients with clinically relevant head and neck cancer-related BID. This score may be used to detect patients who could benefit from strategies to manage their distress, select patients for studies evaluating interventions to manage head and neck cancer-related BID, and improve our understanding of the underlying epidemiology of the disorder

    Excision of large cervical lymphatic malformations using a selective neck dissection approach

    No full text
    Objectives: Lymphatic malformations (LM) are uncommon expansile lesions that may lead to aesthetic or functional impairment requiring intervention. Although recurrence and treatment-related complications are often reported for a subset of patients with extensive cervical LM, primary excision with a selective neck dissection approach is safe and effective. Study design: Case series at a single academic tertiary care center. Methods: Retrospective chart review was performed of clinical presentation, radiographic characteristics, operative notes, and pathology reports of three patients with large cervical LM who underwent complete surgical excision between July 2012 and December 2017. Results: Two-thirds were female with a median age of 39 years (range 34–49 years) All patients had left-sided lesions ranging in size from 6 to 20 cm. Presenting symptoms included increasing neck discomfort and disfigurement. All patients had lesions that were mobile to palpation, macrocystic and well-circumscribed on preoperative imaging without invasion of the upper aerodigestive tract, and without cranial neuropathy. There were no postsurgical cranial nerve issues, complications, or recurrence at a median follow up of 14.7 months (range 10.0–74.9 months). Conclusion: Adult patients with mobile, primarily macrocystic, and well-circumscribed cervical LM with no preoperative cranial nerve deficits are excellent candidates for primary surgical excision, even in cases of exceptionally large multicompartment lesions. If patients are carefully selected, surgery offers the distinct advantage of definitive treatment with a single modality in a single stage and minimal post-treatment morbidity. Keywords: Cervical lymphatic malformation, Congenital malformation, Primary surgical excision, Selective neck dissectio

    Novel voice prosthesis after total laryngectomy with laryngoplasty reconstruction

    Full text link
    BackgroundAlthough many patients achieve serviceable speech after total laryngectomy (TL), others are limited by un‐naturally low pitch. We describe a cadaveric study to provide proof of concept for a novel voice prosthesis after TL with free tissue laryngoplasty.MethodsDevices were implanted into fresh frozen cadavers after TL and free tissue laryngoplasty. Phonation pressures were measured using a custom Blom‐Singer Manometer (InHealth Technologies, Carpinteria, CA) and acoustic files were analyzed using Praat, a speech analysis software.ResultsTwo fresh frozen cadavers were implanted with the voice prosthesis. Both prostheses demonstrated appropriate stenting of the laryngoplasty. Successful sound production was achieved after airflow generation at the proximal trachea. An average phonation pressure of 3.5 cmH2O (SD 1.7 cmH2O) was necessary to generate a sound intensity of 80.6 dB (SD 0.2 dB) at an average fundamental frequency of 299.5 Hz (SD 112.6 Hz).ConclusionsThe novel voice prosthesis described herein offers a feasible voice generation mechanism.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/167126/1/hed26592_am.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/167126/2/hed26592.pd

    Association Between Observer-Rated Disfigurement and Body Image-Related Distress Among Head and Neck Cancer Survivors

    No full text
    This cross-sectional study assesses the association between observer-rated disfigurement and body image–related distress among survivors of head and neck cancer
    corecore